
Abbott Labs (ABT) Stock Forecast & Price Target
Abbott Labs (ABT) Analyst Ratings
Bulls say
Abbott Laboratories is poised for strong growth and success due to its diverse product line, global presence, and commitment to innovation. The company's Medical Devices and Diagnostics segments face competition but remain differentiated due to their focus on technological advancements. Despite potential risks, Abbott's balanced growth trajectory, strong financials and a diversified business model make it a promising investment opportunity.
Bears say
Abbott Laboratories is facing major headwinds in its Medical Devices business due to unfavorable changes in healthcare regulation, pricing, and reimbursement, as well as product safety concerns and product liability. The company's diabetes segment also showed slower growth in Q1 due to a delayed renewal of an international tender and challenging year-over-year comparisons, which could impact future sales. While Abbott maintains a positive outlook for 2026, these factors combined with competition and a weaker-than-expected respiratory season could lead to disappointment for both investors and the company in the future. In the meantime, Abbott's diversified business model and potential for margin expansion could provide some stability.
This aggregate rating is based on analysts' research of Abbott Labs and is not a guaranteed prediction by Public.com or investment advice.
Abbott Labs (ABT) Analyst Forecast & Price Prediction
Start investing in Abbott Labs (ABT)
Order type
Buy in
Order amount
Est. shares
0 shares